Inso Biosciences
PrivateLast Round
Grant
Jun 24, 2026
Total Funding Raised
$5.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inso Biosciences operates in Healthcare & Life Sciences and is based in Ithaca, New York. Its latest recorded funding round was a Grant round in June 2026.
Inso Biosciences is a biotechnology company that develops a cell sample preparation platform designed for genomic analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inso Biosciences Comparables
Compare Inso Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MicroPure Genomics Inc. | 88% | |
| Sage Science | 74% | |
| Revvity, Inc. | 73% |
For institutional investors. Book with your work email.
Inso Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 24, 2026 | ||||
| Seed Round | Mar 3, 2026 | ||||
| Accelerator | Jun 10, 2025 | ||||
| Grant | Jul 1, 2023 | ||||
| Grant | Nov 8, 2022 | ||||
Grant | Sep 19, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inso Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Empire State Development | Grant |
| FuzeHub | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| IndieBio | Pre Seed, Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
$750K raised in Seed Round.
- Sep 19, 2022
$400K grant received from Empire State Development and National Cancer Institute.
For institutional investors. Book with your work email.
Inso Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inso Biosciences's valuation, stock price, and market status.
Is Inso Biosciences a public or private company?
Inso Biosciences is a private company.
What is the current stock price of Inso Biosciences?
Inso Biosciences is a private company, so its shares have no public market price. Caplight tracks Inso Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inso Biosciences worth (valuation)?
Valuation information for Inso Biosciences is not publicly available.
Can I buy Inso Biosciences stock?
Inso Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inso Biosciences's last funding round?
Inso Biosciences's most recent funding round was Grant on June 24, 2026.
Who are the main investors in Inso Biosciences?
Key investors in Inso Biosciences include IndieBio, 2048 Ventures.
Will Inso Biosciences IPO soon?
No public IPO plans have been announced for Inso Biosciences.
How can I track Inso Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Inso Biosciences's shares on secondary markets.